Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion.
about
The role of p21-activated kinases in hepatocellular carcinoma metastasisDeciphering the link between PI3K and PAK: An opportunity to target key pathways in pancreatic cancer?Activation of P21-activated protein kinase 2 is an independent prognostic predictor for patients with gastric cancerPak2 regulates hematopoietic progenitor cell proliferation, survival, and differentiationGL-1196 Suppresses the Proliferation and Invasion of Gastric Cancer Cells via Targeting PAK4 and Inhibiting PAK4-Mediated Signaling PathwaysP21-activated kinase-2 is a critical mediator of transforming growth factor-β-induced hepatoma cell migrationGroup I PAK inhibitor IPA-3 induces cell death and affects cell adhesivity to fibronectin in human hematopoietic cellsLC-0882 targets PAK4 and inhibits PAK4-related signaling pathways to suppress the proliferation and invasion of gastric cancer cells.Comparison of expression profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesis.p21-Activated kinase-1 promotes aggressive phenotype, cell proliferation, and invasion in gestational trophoblastic disease.Motility of select ovarian cancer cell lines: effect of extra-cellular matrix proteins and the involvement of PAK2p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patientsPAK1 mediates resistance to PI3K inhibition in lymphomas.Overexpression of forkhead box protein M1 (FOXM1) in ovarian cancer correlates with poor patient survival and contributes to paclitaxel resistanceReduced expression of p21-activated protein kinase 1 correlates with poor histological differentiation in pancreatic cancer.Proteomic analyses of serous and endometrioid epithelial ovarian cancers - cases studies - molecular insights of a possible histological etiology of serous ovarian cancer.PAK1 as a therapeutic target.Promotion of liver and lung tumorigenesis in DEN-treated cytoglobin-deficient micep21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell Proliferation.PAK1 is a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome.Paradoxical impact of two folate receptors, FRα and RFC, in ovarian cancer: effect on cell proliferation, invasion and clinical outcome.Overexpression of PAK-1 is an independent predictor of disease recurrence in colorectal carcinomaDifferential mRNA expression levels of human histone-modifying enzymes in normal karyotype B cell pediatric acute lymphoblastic leukemia.Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasionPAK2 promotes migration and proliferation of salivary gland adenoid cystic carcinomap21-activated kinase 1 (PAK1) expression correlates with prognosis in solid tumors: A systematic review and meta-analysisThe Role of Ect2 Nuclear RhoGEF Activity in Ovarian Cancer Cell Transformation.Functional proteomics to dissect tyrosine kinase signalling pathways in cancer.The 11q13-q14 amplicon: clinicopathological correlations and potential drivers.Clinicopathological and cellular signature of PAK1 in human bladder cancer.Association of p21-activated kinase-1 activity with aggressive tumor behavior and poor prognosis of head and neck cancer.PP1α, PP1β and Wip-1 regulate H4S47 phosphorylation and deposition of histone H3 variant H3.3.MiR-98 inhibits cell proliferation and invasion of non-small cell carcinoma lung cancer by targeting PAK1.p21-activated kinase 1 predicts recurrence and survival in patients with non-metastatic clear cell renal cell carcinoma.MicroRNA miR-4779 suppresses tumor growth by inducing apoptosis and cell cycle arrest through direct targeting of PAK2 and CCND3.Expression of P21-activated kinase 1 and cell division control protein 42 homolog correlates with clinicopathological features and prognosis in cervical carcinoma.Overexpression of dedicator of cytokinesis I (Dock180) in ovarian cancer correlated with aggressive phenotype and poor patient survival.Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers.
P2860
Q27016620-466C8932-C818-438F-83B5-9AC527B29563Q28079848-FB8D719D-37F2-4500-A86D-563C335C58C1Q28235791-7C64C627-C16A-428C-9A78-EE990FB86EA5Q28255514-C5015F52-4660-4055-B77A-D488E64EC7E2Q28274863-E4830D7A-150A-42C8-948D-63B6DE402EDDQ28285920-DB645CCA-D1E1-4F35-B2C2-A5476EE3A9C2Q28541395-00ACCBFB-7678-4B87-A272-647EAE951005Q33850221-37004FFC-ACFF-468F-9D51-9386474EB275Q33851325-9FF78EBC-0D6B-460A-A66E-BEE957A5F9CFQ33882580-B9BCEE7A-BAA2-48B0-AB5F-4A5575F9C645Q34120393-E8779C13-B07C-41DA-B584-6F9AA9E6696AQ34276605-7D49EC7D-600E-4736-8460-8EB97A8D7F67Q34539577-C5462DC0-6C56-4420-B01F-E7A18BDCCD93Q34550042-B09BCECE-9188-4516-AC22-605D299B2697Q34566032-1690B624-41D4-4BD8-9E18-C63AEE1FA176Q34669870-214C82D3-240C-4EA7-94DF-2E900C9E50BBQ35108164-592A5EAE-7EA8-4B14-9EBB-28DE8BEFCFAAQ35168131-9F963D04-CEAE-46D5-AB08-D210B953973EQ35720268-69EF63FC-E199-422C-96A3-0FDFA4D86F25Q36000867-64EE704B-0144-4FFF-ABFC-90F7954D23C2Q36380927-63B7A70A-C604-4FE4-B5C1-71D9ED768F1DQ36511751-09BD8FAB-2956-4A0E-A8D6-8EC7BBB31082Q36656083-31B757B0-10BB-432E-9446-68B030E7DB7BQ37030373-82AD6BB3-56F7-4BA3-8FAA-63EA8A20F6BCQ37227966-1D839923-7661-4FB0-9F13-D0F49400C5E2Q37317276-86A87721-95E9-4C63-8069-3ABA08434F7BQ37424400-DEAC03AB-F410-40CB-9B55-914FDE3A046DQ37780948-551D76C1-D40A-4877-AB89-A4CD2ED06B38Q38066149-DB6C0942-9C43-4337-86DB-0D5DB994F082Q38938813-FB0636D8-8183-4DA8-B2D1-DC380815546CQ39014879-8443937C-534A-4DE4-A11D-3413AF1FA4CBQ39130206-3CE60A36-547D-4269-AD7D-29088B1E4478Q41830881-B818B2EF-654B-436C-AD2B-99321E630EE8Q46203111-48E88B19-B8B4-4CA7-BD9E-8639C178EBDDQ48525965-FB3AD14D-9DD4-4552-9A68-93652738E6EFQ52876012-8E8F3029-94CB-44D2-96F3-0569E8B736D1Q53198380-61E017C8-A5FD-4B1D-894F-3622BBAD62ACQ53264975-7AAAC085-AE8D-4D34-B454-D891C70ABA14
P2860
Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Differential expression and ph ...... n prognosis and cell invasion.
@en
Differential expression and ph ...... n prognosis and cell invasion.
@nl
type
label
Differential expression and ph ...... n prognosis and cell invasion.
@en
Differential expression and ph ...... n prognosis and cell invasion.
@nl
prefLabel
Differential expression and ph ...... n prognosis and cell invasion.
@en
Differential expression and ph ...... n prognosis and cell invasion.
@nl
P2093
P2860
P356
P1476
Differential expression and ph ...... on prognosis and cell invasion
@en
P2093
Daniel S H Kong
Dominic C W Chan
Esther S Y Wong
Hoi Yan Chan
Kar Fai Tam
Kelvin Y K Chan
Michelle K Y Siu
Nina W S Woo
Queeny K Y Chan
P2860
P356
10.1002/IJC.25005
P577
2010-07-01T00:00:00Z